Global Phosphoramidite Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated:
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Phosphoramidite Market was valued at $1.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 7.8% CAGR, to an estimated market size of $1.8 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global phosphoramidite market comprises the production and supply of chemical building blocks (reagents) essential for the solid-phase synthesis of oligonucleotides, including DNA, RNA, and modified nucleic acids. These reagents are critical for applications in molecular diagnostics, gene therapy, mRNA vaccines, and synthetic biology, while excluding alternative enzymatic synthesis methods that do not utilize phosphoramidite chemistry.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Phosphoramidite Market in the period 2025-30:
- The rapid expansion of the oligonucleotide therapeutics pipeline, particularly for antisense and siRNA drugs, is driving massive demand for high-volume reagent supply.
- Increased adoption of mRNA-based vaccines and therapies is accelerating the growth of the RNA phosphoramidite segment relative to traditional DNA types.
- A significant shift toward GMP-grade reagents is occurring as more oligonucleotide-based candidates move from discovery into late-stage clinical trials.
- The integration of AI and automation in high-throughput synthesis platforms is improving manufacturing scalability and reducing the cost of custom sequences.
- Rising utilization of CRISPR-Cas9 and other gene-editing tools is fueling the need for high-purity, modified phosphoramidites for guide RNA synthesis.
- Growing emphasis on green chemistry and solvent recycling mandates, particularly in Europe, is pushing manufacturers to develop more sustainable synthesis processes.
- Supply chain vulnerabilities for raw materials like protected nucleosides are prompting a strategic shift toward localized manufacturing in North America and Europe.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Asia-Pacific
- Europe
- Rest of World
Segments
- DNA Phosphoramidites
- RNA Phosphoramidites
- Labeled & Modifier Phosphoramidites